Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR)
- Navarro-Zaragoza, J.
- Laorden, M.L.
- Milanés, M.V.
ISSN: 1879-3185, 0300-483X
Year of publication: 2014
Volume: 326
Pages: 36-43
Type: Article